ELZONRIS

Stemline Therapeutics, Inc.

Application Filed: 2018-03-21
Trademark Application Details
Trademark Logo ELZONRIS

Mark For: ELZONRIS® trademark registration is intended to cover the categories of pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases. [all]

Status

2020-05-09 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number87843152
Registration Number5782895
Mark Literal ElementsELZONRIS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2019-05-15
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJessica S. Parise
Attorney Docket NumberSTT-607
Law Office AssignedM20
Employee NameWATTS-FITZGERALD, CAIT

Timeline

2018-03-21Application Filed
2018-12-13Location: TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
2018-12-13Status: Live/Pending
2019-01-07Transaction Date
2019-01-23Date of First Use
2019-01-23Date of Use In Commerce
2019-02-12Published
2019-02-12Published for Opposition
2019-05-15Location: PUBLICATION AND ISSUE SECTION
2019-06-18Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-06-18Trademark Registered
2024-06-18Maintenance Early File Date
2025-06-18Maintenance On Time Date
2025-12-18Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: Stemline Therapeutics, Inc.
Address750 Lexington Avenue, 11th Floor New York, NEW YORK UNITED STATES 10022
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

JESSICA S. PARISE
GOODWIN PROCTER LLP
620 EIGHTH AVENUE
THE NEW YORK TIMES BUILDING
NEW YORK, NY 10018

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases. FIRST USE: 20190123. FIRST USE IN COMMERCE: 20190123

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
TR0010The wording ELZONRIS has no meaning in a foreign language.
GS0051pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2019-06-18
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2019-05-16
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2019-05-15
STATEMENT OF USE PROCESSING COMPLETE2019-04-2366230
CASE ASSIGNED TO INTENT TO USE PARALEGAL2019-04-2366230
USE AMENDMENT FILED2019-04-1066230
TEAS STATEMENT OF USE RECEIVED2019-04-10
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-04-09
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-02-18
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-02-18
PUBLISHED FOR OPPOSITION2019-02-12
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-02-12
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-01-23
LAW OFFICE PUBLICATION REVIEW COMPLETED2019-01-0970629
ASSIGNED TO LIE2019-01-0770629
APPROVED FOR PUB - PRINCIPAL REGISTER2018-12-13
TEAS/EMAIL CORRESPONDENCE ENTERED2018-12-1288889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2018-12-12
CORRESPONDENCE RECEIVED IN LAW OFFICE2018-12-1288889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-07-036325
NON-FINAL ACTION WRITTEN2018-07-0389010
NON-FINAL ACTION E-MAILED2018-07-036325
ASSIGNED TO EXAMINER2018-07-0389010
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-03-28
NEW APPLICATION ENTERED IN TRAM2018-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed